Evaluating the results of the Momguard noninvasive prenatal test
Journal of Genetic Medicine
;
: 96-99, 2015.
Artigo
em Inglês
| WPRIM
| ID: wpr-195764
ABSTRACT
PURPOSE:
To evaluate the performance of the Momguard noninvasive prenatal test by tracing the 'screen positive' results based on preliminary samples from Korean cohorts. MATERIALS ANDMETHODS:
This preliminary study is based on data collected by the LabGenomics Clinical Laboratory (Seongnam, Korea) with informed consent. Only pregnant women who underwent both the Momguard test and karyotyping were included in this study. Momguard test results were compared with those of the karyotyping analysis.RESULTS:
Among the 38 cases with 'screen positive' results by Momguard, 30 cases also had karyotyping results available. In three trisomy (T) 18 and three T13 cases, the Momguard results were concordant with the karyotyping results. For the T21 cases, except for one case belonging to the mid-risk zone, Momguard results from 23 out of 24 cases matched the karyotyping results.CONCLUSION:
Momguard is a highly reliable screening tool for detecting T13, T18, and T21 cases in independent Korean cohort samples.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Diagnóstico Pré-Natal
/
Trissomia
/
Programas de Rastreamento
/
Estudos de Coortes
/
Síndrome de Down
/
Gestantes
/
Consentimento Livre e Esclarecido
/
Cariotipagem
/
Aneuploidia
Tipo de estudo:
Estudo diagnóstico
/
Estudo de etiologia
/
Estudo de incidência
/
Estudo observacional
/
Fatores de risco
/
Estudo de rastreamento
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Journal of Genetic Medicine
Ano de publicação:
2015
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS